mesalamine and allopurinol

mesalamine has been researched along with allopurinol in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's4 (36.36)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Barbara, L; Belluzzi, A; Brignola, C; Campieri, M; Gionchetti, P; Guarnieri, C; Iannone, P; Miglioli, M1
Imamura, S; Miyachi, Y; Niwa, Y; Yoshioka, A1
Depace, DE; Fondacaro, JD; Hui-Qi, Q; Murthy, S; Sakai, T1
Broström, O; Danielsson, A; Florén, C; Hultcrantz, R; Järnerot, G; Kilander, A; Löfberg, R; Lööf, L; Nilsson, A; Ström, M1
Banna, N; Dawson, C; Hawkins, C; Langmead, L; Loo, S; Rampton, DS1
Broekman, MM; de Jong, DJ; Hoentjen, F; Kerstholt, M; Leijten, A; Peters, WH; Roelofs, HM; Wanten, GJ; Wong, DR1
Andoh, A; Bamba, S; Inatomi, O; Kawahara, M; Morita, Y; Nishida, A; Sasaki, M; Sugimoto, M; Takahashi, K1

Reviews

1 review(s) available for mesalamine and allopurinol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for mesalamine and allopurinol

ArticleYear
Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:9

    Topics: Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Sweden

2000

Other Studies

9 other study(ies) available for mesalamine and allopurinol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
    Digestive diseases and sciences, 1991, Volume: 36, Issue:2

    Topics: Aminosalicylic Acids; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; In Vitro Techniques; Luminescent Measurements; Mesalamine; Neutrophils; Spectrophotometry; Sulfasalazine; Superoxides; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines

1991
Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Gut, 1987, Volume: 28, Issue:2

    Topics: Adult; Aminosalicylic Acids; Antioxidants; Cell-Free System; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Luminescent Measurements; Mesalamine; Neutrophils; Sulfapyridine; Sulfasalazine; Superoxides; Xanthine Oxidase; Xanthines; Zymosan

1987
Ischemia/reperfusion injury in the rat colon.
    Inflammation, 1997, Volume: 21, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Aerobiosis; Aminosalicylic Acids; Anaerobiosis; Animals; Antioxidants; Arachidonic Acid; Colon; Disease Models, Animal; Glutathione; Lactic Acid; Male; Mesalamine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Thromboxane B2; Vitamin E; Xanthine Oxidase

1997
Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cells, Cultured; Colonoscopy; Dose-Response Relationship, Drug; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Phytotherapy; Plant Preparations; Xanthine Oxidase

2002
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
    Cell biology and toxicology, 2015, Volume: 31, Issue:3

    Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Cell Line, Tumor; Hepatocytes; Humans; Mercaptopurine; Mesalamine

2015
pH-Dependent 5-Aminosalicylates Releasing Preparations Do Not Affect Thiopurine Metabolism.
    Digestion, 2019, Volume: 100, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Drug Interactions; Drug Liberation; Female; Guanine Nucleotides; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Retrospective Studies; Thionucleotides; Time Factors; Young Adult

2019